| Financial Year |
March 31 2023 |
| Monetary Funds |
1,254,690,747.06 |
| Held-for-trading Financial Assets |
5,230,000.00 |
| Notes Receivable |
17,703,653.19 |
| Accounts Receivable |
1,849,817,896.33 |
| Advances to Suppliers |
99,305,613.48 |
| Other Receivables |
21,346,406.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,924,664,493.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,074,294.92 |
| Total Current Assets |
6,327,884,233.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
75,228,081.43 |
| Investment Properties |
-- |
| Fixed Assetes |
874,624,821.99 |
| Under-construction Projects |
15,039,823.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,085,364.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,108,704.41 |
| Deferred Income Tax Assets |
44,144,445.23 |
| Other Non-Current Assets |
26,822,849.39 |
| Sub-Total of Non-Current Assets |
1,246,298,161.82 |
| Total Assets |
7,574,182,395.21 |
| Short-Term Loans |
590,383,197.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
573,344,455.98 |
| Accounts Payable |
1,164,400,660.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
76,150,420.68 |
| Taxes Payable |
107,606,004.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,273,936.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
202,227,236.87 |
| Other Current Liabilities |
33,153,503.17 |
| Sub-Total of Current Liabilities |
3,055,309,497.86 |
| Long-term Loans |
631,177,525.03 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,932,142.26 |
| Deferred Income Tax Liabilities |
4,976,987.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
681,214,952.33 |
| Total Liabilities |
3,736,524,450.19 |
| Paid-In Capital(Or Share Stock) |
444,305,790.00 |
| Capital Surplus |
1,825,827,043.70 |
| Surplus Reserve |
132,344,707.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,448,566,100.45 |
| Minority Stockholder's Interest |
24,685,634.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,812,972,310.98 |
| Owner's Equity（Stockholder's Equity） |
3,837,657,945.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,574,182,395.21 |
